Discover investment opportunities in Top 100 Stocks Under $1 using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Top 100 Stocks Under $1 using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Top 100 Stocks Under $1 using our Smart AI Filter.
7 stocks found for "Top 100 Stocks Under $1"
Security name | Expected returns | Sharpe Ratio | Beta | Volatility | P/E Ratio | Dividend Yield |
|---|---|---|---|---|---|---|
1.11 Risk measure | ±100.0% Price volatility | — Valuation | 0.00% Annual yield | |||
1.56 Risk measure | ±83.0% Price volatility | -16.0 Valuation | 0.00% Annual yield | |||
0.76 Risk measure | ±100.0% Price volatility | -0.1 Valuation | 0.00% Annual yield | |||
1.01 Risk measure | ±72.3% Price volatility | -3.1 Valuation | 0.00% Annual yield | |||
0.65 Risk measure | ±93.4% Price volatility | -1.0 Valuation | 0.00% Annual yield | |||
0.64 Risk measure | ±100.0% Price volatility | -0.4 Valuation | 0.00% Annual yield | |||
0.15 Risk measure | ±100.0% Price volatility | -0.2 Valuation | 0.00% Annual yield |
This search uses our Smart AI Filter to identify stocks matching your criteria. Results are ranked by relevance and include key financial metrics to help you make informed investment decisions.
Get personalized stock recommendations, save custom screens, and access premium filters. All our screening tools are free—signing up gives you more personalized results and the ability to save your research.
Compliance disclosure:
The securities listed on this website have not paid to be included in the results. The inclusion of any securities in the results shown does not imply any relationship with PortfolioPilot. The order of the results is ranked based on the Sharpe Ratio, which is a measure of risk-adjusted return. Please note that these listings are not recommendations or financial advice. Past performance is not indicative of future results.
Q: How has VXRT performed in past economic downturns?
A: Historically, Vaxart Inc. (VXRT) has shown volatility in response to economic cycles due to its position in the biotech sector, which can be unpredictable. Investors should research specific downturn-related performance for more detailed insights.
Q: What factors might influence the growth potential for ONCY?
A: Oncolytics Biotech Inc. (ONCY) focuses on cancer therapeutics. Growth potential may be tied to FDA approvals, clinical trial successes, and partnerships in the oncology sector.
Q: Do any stocks under $1 on this page offer dividends?
A: Typically, stocks priced under $1, like those listed here, rarely offer dividends as they often reinvest profits into growth. Investors should verify directly with each company's financial announcements.
Q: What are sector-specific strengths of CGEN?
A: Compugen Ltd. (CGEN) leverages its computational biology capabilities within the biotech sector, aiming to identify novel therapeutic targets, offering a potential competitive edge.
Q: Are there geographic factors affecting KXIN's stock performance?
A: Kaixin Auto Holdings (KXIN), based in China, could be influenced by regulatory changes, automotive market trends, and U.S.-China relations, impacting its stock performance.
Q: How might VTAK respond to technological advancements?
A: Viracta Therapeutics (VTAK) may benefit from advancements in bioinformatics and genomic technologies, potentially enhancing its cancer treatment research efficacy.
Oncolytics Biotech (ONCY) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
Read moreKaixin Auto Holdings (NASDAQ: KXIN) revealed that Beijing Camping Club Sports and Culture Communication Co Ltd (Camping Club) has agreed to order about 20,000 new energy vehicles over the next five years. The value of the order totals RMB6 billion ($938 million).
Read more